NCT06897969

Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment

Comparison of Intralesional Triamcinolone and Intralesional Verapamil in the Treatment of Keloids

• Status: Not Yet Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Nishtar Medical University · Academic / Other
• Sex: All
• Age: 10 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

This study aims to compare the efficacy of intralesional triamcinolone and verapamil in patients presenting with keloid at our local setting. The results will guide us towards better management of keloids by choosing the more appropriate treatment. Adequate treatment will reduce significant emotional and physical distress in patients. We hypothesized that mean reduction in Vancouver Scar Score is higher in triamcinolone acetonide group compared to verapamil after three months of treatment.

Conditions

• Keloid Scars

Interventions

Type	Name	Description
DRUG	Triamcinolone Acetonide 1 ml of 40 mg/mL suspension	Monthly intralesional injection
DRUG	Verapamil Injection	2.5 mg of intralesional Verapamil injection monthly

Timeline

• Start date: 2025-04-01
• Primary completion: 2025-09-30
• Completion: 2025-09-30
• First posted: 2025-03-27
• Last updated: 2025-04-01

Locations

1 site across 1 country: Pakistan